• Main Menu
  • ABOUT
    • About Amgen

      Amgen has had a presence in Ireland for over 25 years. We established our Irish commercial operation in 1998 and we now employ 1,250 people across our three sites.

    • Amgen History

      Explore Amgen's extensive history of over 40 years, marked by groundbreaking therapeutic innovation. Learn about our journey shaping the future of healthcare.

    • Mission and Values

      Amgen's mission is to harness the potential of science and biotechnology to develop life-saving therapies, guided by values like ethics, teamwork, and quality.

    • Contact

      Connect with Amgen for inquiries and assistance. Access our contact form and essential information on media, investors, careers, and more.

    • Our Medicines

      Discover Amgen's array of innovative prescription drugs aimed at treating serious illnesses. Explore our impactful therapies dedicated to improving lives.

    • Transparency

      Access Amgen's transparency reports. Learn about our commitment to openness and accountability.

    • Awards

      At Amgen, our journey towards making a positive impact on patients' lives and advancing the field of biotechnology is marked by a series of prestigious awards and recognitions.

    • Leadership

      Meet Amgen's esteemed leadership team driving innovation and excellence in biotechnology. Learn about our leaders and their roles in shaping healthcare.

  • Science
    • Overview

      Discover how Amgen's innovations in biotechnology are shaping the future of medicine. Explore our pioneering role in advancing science to transform lives.

    • Biotechnology
    • Discovering And Developing Medicines

    • The Science Of Biotechnology

    • Biomanufacturing

    • How Are Medicines Made

    • Biosimilars

      Explore Amgen's expertise in biosimilars backed by over 40 years of biotechnology experience. Learn about biosimilar basics, manufacturing, and more.

    • Clinical trials

      Understanding clinical trials, including risks, benefits, placebos, participation, and regulations. Learn how to get involved and what to expect.

  • THERAPEUTIC AREAS
    • Overview

      Explore Amgen's commitment to advancing healthcare across key areas: oncology, cardiovascular disease, osteoporosis, and more.

    • Pharmacovigilance

      Learn more about Amgen's commitment to patient safety and how to report a potential side effect or product quality issue.

  • Responsibility
    • Overview

      Amgen strives to make a difference through the Foundation, environmental initiatives, ethics, and more. Discover our impactful programs and achievements.

    • Environment, Social and Governance

      Explore Amgen's ESG commitment for a better world: Healthy People, Society, Planet, and a Healthy Amgen. Serving patients and global well-being.

    • Diversity Inclusion and Belonging

      Diversity matters at Amgen. We believe that an environment of inclusion fosters innovation, which drives our ability to serve patients.

    • Environmental Sustainability

      Discover Amgen's commitment to fostering a sustainable world. Explore our efforts to innovate responsibly and drive positive environmental impact.

    • Ethics and Compliance

      Amgen upholds ethical conduct and transparency in all business operations. Explore our Code of Conduct, Compliance Policy, and reporting mechanisms.

    • The Amgen Foundation

      The Amgen Foundation is committed to advancing excellence and expanding access to science education.

    • Sponsorships

      We have had a presence in Ireland for a quarter century and we are very proud of our support for the community through our sponsorships.

  • Newsroom
  • Working at Amgen
  • amgen-worldwide-web
  • linkedIn-icon
  • linkedIn-icon
  1. Home
    >
  2. Science
    >
  3. Biotechnology
    >
  4. The Science of Biotechnology
    >

The Science of Biotechnology

By selecting the Yes option, leaving Amgen.ie option you understand that you are leaving the corporate page of Amgen Ireland and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Europe is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.

The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Europe. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.

yes, leave amgen.ie CANCEL

Biotechnology has been used in a rudimentary form since ancient brewers began using yeast cultures to make beer. The breakthrough that laid the groundwork for modern biotechnology came when the structure of DNA was discovered in the early 1950s. To understand how this insight eventually led to biotech therapies, it’s helpful to have a basic understanding of DNA’s central role in health and disease.

WHAT DOES DNA DO?

DNA is a very long and coiled molecule found in the nucleus, or command center, of a cell. It provides the full blueprint for the construction and operation of a life-form, be it a microbe, a bird, or a human. The information in DNA is stored as a code made up of four basic building blocks, called nucleotides. The order in which the nucleotides appear is akin to the order of the letters that spell words and form sentences and stories. In the case of DNA, the order of nucleotides forms different genes. Each gene contains the instructions for a specific protein.

With a few exceptions, every cell in an organism holds a complete copy of that organism’s DNA. The genes in the DNA of a particular cell can be either active (turned on) or inactive (turned off) depending on the cell’s function and needs. Once a gene is activated, the information it holds is used for making, or “expressing,” the protein for which it codes. Many diseases result from genes that are improperly turned on or off.

  • HOW DOES THE BODY MAKE A PROTEIN?

    Protein production is a multistep process that includes transcription and translation. During transcription, the original DNA code for a specific protein is rewritten onto a molecule called messenger RNA (mRNA); mRNA has nucleotides similar to those of DNA. Each successive grouping of three nucleotides forms a codon, or code, for one of 20 different amino acids, which are the building blocks of proteins.

    During translation, a cell structure called a ribosome binds to a ribbon of mRNA. Other molecules, called transfer RNAs, assemble a chain of amino acids that matches the sequence of codons in the mRNA. Short chains of amino acids are called peptides. Long chains, called polypeptides, form proteins.

  • WHAT FUNCTIONS DO PROTEINS CONTROL?

    The amino acids that form a protein interact with each other, and those complex interactions give each protein its own specific, three-dimensional structure. That structure in turn determines how a protein functions and what other molecules it impacts. Common types of proteins are:

    • Enzymes, which put molecules together or break them apart.
    • Signaling proteins, which relay messages between cells, and receptors, which receive signals sent via proteins from other cells.
    • Immune system proteins, such as antibodies, which defend against disease and external threats.
    • Structural proteins, which give shape to cells and organs.

    Given the tremendous variety of functions that proteins perform, they are sometimes referred to as the workhorse molecules of life. However, when key proteins are malfunctioning or missing, the result is often disease of one type or another.

How does genetic engineering work?

Genetic engineering is the cornerstone of modern biotechnology. It is based on scientific tools, developed in recent decades, that enable researchers to:

  • Identify the gene that produces the protein of interest.
  • Cut the DNA sequence that contains the gene from a sample of DNA.
  • Place the gene into a vector, such as a plasmid or bacteriophage.
  • Use the vector to carry the gene into the DNA of the host cells, such as Escherichia coli (E. coli) or mammalian cells grown in culture.
  • Induce the cells to activate the gene and produce the desired protein.
  • Extract and purify the protein for therapeutic use.

When segments of DNA are cut and pasted together to form new sequences, the result is known as recombinant DNA. When recombinant DNA is inserted into cells, the cells use this modified blueprint and their own cellular machinery to make the protein encoded by the recombinant DNA. Cells that have recombinant DNA are known as genetically modified or transgenic cells.

  • Genetic Engineering Tools

    To manipulate cells and DNA, scientists use tools that are borrowed from nature, including:

    RESTRICTION ENZYMES

    These naturally occurring enzymes are used as a defense by bacteria to cut up DNA from viruses. There are hundreds of specific restriction enzymes that researchers use like scissors to snip specific genes from DNA.

    DNA LIGASE

    This enzyme is used in nature to repair broken DNA. It can also be used to paste new genes into DNA.

    PLASMIDS

    These are circular units of DNA. They can be engineered to carry genes of interest.

    BACTERIOPHAGES (ALSO KNOWN AS PHAGES)

    These are viruses that infect bacteria. Bacteriophages can be engineered to carry recombinant DNA.

Genetic engineering allows scientists to manufacture molecules that are too complex to make with chemistry. This has resulted in important new types of therapies, such as therapeutic proteins. Therapeutic proteins include those described below as well as ones that are used to replace or augment a patient’s naturally occurring proteins, especially when levels of the natural protein are low or absent due to disease. They can be used for treating such diseases as cancer, blood disorders, rheumatoid arthritis, metabolic diseases and diseases of the immune system.

Examples of genetically engineered molecules

  • Monoclonal antibodies are a specific class of therapeutic proteins made by the immune system to target and help destroy foreign invaders such as bacteria, viruses and cancer cells.
  • Peptibodies are engineered proteins that have the biological activity of a peptide and the longer duration of an antibody.
  • Vaccines stimulate the immune system to provide protection, mainly against viruses. Traditional vaccines use weakened or killed viruses to prime the body to attack the real virus. Biotechnology can create recombinant vaccines based on viral genes.

These new modes of treatment give drug developers more options in determining the best way to counteract a disease. But biotechnology research and development (R&D), like pharmaceutical R&D, is a long and demanding process with many hurdles that must be cleared to achieve success.

Discovering and Developing Medicines

Unlocking disease mysteries at the molecular level. Explore our research journey to uncover targets for innovative medicines and transformative therapies.

How are Biotechnology Medicines Made?

Explore Amgen's pioneering biologics manufacturing—an intricate dance of living cells, guided by unparalleled expertise, shaping the future of medicine.

Amgen logoAmgen logo

Biotechnology

Unveiling the transformative world of biotechnology medicines at Amgen. Learn about our evolution, development, and significant impact on healthcare.

Contact Us Cookie Preferences Cookie Statement Terms of Use Privacy Statement Sitemap

Amgen Social Media

© 2024, 2025 Amgen Inc. All rights reserved.